Executive Team

  • Chris Venter, CEO

    25 years+ international experience in deal making, finance, value creation, business development, risk management and problem solving across diverse Industries.

  • Dr. Dave Farrell, Founder and CSO

    41 years of research in the areas of hemostasis, thrombosis and blood coagulation, 27 years as a Principal Investigator; Professor of Surgery, Department of Surgery, Division of Trauma, Critical Care and Acute Care Surgery, Oregon Health & Science University.

  • Ajay Nair, Board Chairman

    Driven commercial leader, with 20+ years of healthcare industry expertise, building best-in-class sales and marketing teams globally, broad experience in commercial execution and international channel management.

  • Gerry Mabarrack, Head of Business Development

    Starting his career as a medical scientist, with 30+ years of diagnostic pathology experience and 25+ years in ascendind senior leadership and executive management roles, he brings an immense network and knowledge of the diagnostic industry.

Clinical Advisors

  • Prof. John Olynyk, Medical Advisor

    Prof. Olynyk is an internationally recognized leader in liver-related diseases including iron-metabolism disorders, hemochromatosis, liver-injury, hepatocellular carcinoma, and non-alcoholic fatty liver disease (“NAFLD”)

  • Prof. Steve Kazmierczak (PhD), Advisor

    Expert in the clinical diagnostic industry, including writing CLSI standards. Director of Clinical Chemistry and Toxicology at Oregon Health & Science University Hospital.

  • Dr. C N Ramchand (PhD)

    Industrial and academic background in the field of drug discovery, nanotechnology and nutraceuticals. Expert in Drug discovery, Development and Commercialization. Entrepreneur of multiple successful start ups.